Practical implication
Healthcare establishments must quarantine the affected Eyefill C lots, refrain from using them, and monitor patients who received the device.
On September 3, 2026, the French medicines regulator ANSM announced that Bausch + Lomb is recalling certain lots of its Eyefill C device (SKU EYEFILL-C-B) following reports of damaged blisters containing pre-filled syringes, which may compromise sterility. Affected lots must be quarantined immediately, and while no patient impact has been reported, monitoring post-operative patients who received the affected product is necessary.
What changed: Voluntary recall initiated for specific Eyefill C device lots due to potential sterility issues.
Why it matters: There is a risk of irreversible eye damage if a compromised viscoelastic device is used during cataract surgery, even without any reported patient injuries.
Practical implication: Healthcare establishments must quarantine the affected Eyefill C lots, refrain from using them, and monitor patients who received the device.
View original source
- Source: ANSM (France) - Safety information feed
- Published at source: 2026-09-03T00:00:00.000Z
- Discovered by monitor: 2026-09-03T21:47:55.806Z
Published from the regulator source ingestion pipeline after PV impact triage.
